Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid(50)-L-tyrosine(50) induced in BALB/c mice by cyclophosphamide

por Debre, P, Waltenbaugh, C, Dorf, ME, Benacerraf, B
Publicado 1976

Genetic control of specific immune suppression. III. Mapping of H-2 complex complementing genes controlling immune suppression by the random copolymer L-glutamic acid(50)-L-Tyrosin...

por Debre, P, Waltenbaugh, C, Dorf, M, Benacerraf, B
Publicado 1976

P19-25. A vaccine model to prevent the depletion of uninfected bystander CD4 cells during HIV infection

por Vieillard, V, Fausther-Bovendo, H, Le Grand, R, Debre, P
Publicado 2009

OA031-05. HIV escape from natural killer cytotoxicity: Nef inhibits NKp44L expression on HIV-infected CD4+ T cells

por Fausther-Bovendo, H, Sol-Foulon, N, Schwartz, O, Debre, P, Vieillard, V
Publicado 2009

COVID-19 epidemic phases: Criteria, challenges and issues for the future()

por Migus, A., Netter, P., Boitard, C., Clement, B., Allilaire, J.-F., Ardaillou, R., Berche, P., Charpentier, B., Debre, P., Galibert, F., Nordlinger, B.
Publicado 2020

Les phases de l’épidémie du Covid-19 : critères, défis et enjeux pour le futur()()()

por Migus, A., Netter, P., Boitard, C., Clement, B., Allilaire, J.-F., Ardaillou, R., Berche, P., Charpentier, B., Debre, P., Galibert, F., Nordlinger, B.
Publicado 2020